KERX
BNP Paribas Financial Markets’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-30,498
| Closed | -$104K | – | 3780 |
|
|
2018
Q3 | $104K | Buy |
30,498
+151
| +0.5% | +$513 | ﹤0.01% | 2074 |
|
|
2018
Q2 | $114K | Buy |
30,347
+7,974
| +36% | +$30K | ﹤0.01% | 2092 |
|
|
2018
Q1 | $91.5K | Buy |
22,373
+772
| +4% | +$3.16K | ﹤0.01% | 2657 |
|
|
2017
Q4 | $100K | Buy |
21,601
+11,998
| +125% | +$55.8K | ﹤0.01% | 2650 |
|
|
2017
Q3 | $68.2K | Sell |
9,603
-549
| -5% | -$3.9K | ﹤0.01% | 2560 |
|
|
2017
Q2 | $73.4K | Buy |
10,152
+8,514
| +520% | +$61.6K | ﹤0.01% | 2533 |
|
|
2017
Q1 | $10.1K | Sell |
1,638
-3,999
| -71% | -$24.6K | ﹤0.01% | 2646 |
|
|
2016
Q4 | $33K | Sell |
5,637
-1,089
| -16% | -$6.38K | ﹤0.01% | 2535 |
|
|
2016
Q3 | $35.7K | Buy |
6,726
+3,693
| +122% | +$19.6K | ﹤0.01% | 2585 |
|
|
2016
Q2 | $20.1K | Buy |
+3,033
| New | +$20.1K | ﹤0.01% | 2586 |
|
|
2016
Q1 | – | Sell |
-23,664
| Closed | -$120K | – | 3355 |
|
|
2015
Q4 | $120K | Buy |
23,664
+2,244
| +10% | +$11.3K | ﹤0.01% | 2215 |
|
|
2015
Q3 | $75.4K | Buy |
21,420
+12,802
| +149% | +$45.1K | ﹤0.01% | 2572 |
|
|
2015
Q2 | $86K | Buy |
8,618
+6,624
| +332% | +$66.1K | ﹤0.01% | 2159 |
|
|
2015
Q1 | $25.4K | Buy |
+1,994
| New | +$25.4K | ﹤0.01% | 2254 |
|
|
2014
Q4 | – | Sell |
-6,041
| Closed | -$83.1K | – | 3179 |
|
|
2014
Q3 | $83.1K | Buy |
6,041
+5,785
| +2,260% | +$79.5K | ﹤0.01% | 1928 |
|
|
2014
Q2 | $3.94K | Buy |
256
+136
| +113% | +$2.09K | ﹤0.01% | 2249 |
|
|
2014
Q1 | $1.77K | Sell |
120
-940
| -89% | -$13.9K | ﹤0.01% | 2259 |
|
|
2013
Q4 | $13.7K | Sell |
1,060
-21,469
| -95% | -$278K | ﹤0.01% | 2001 |
|
|
2013
Q3 | $227K | Sell |
22,529
-6,453
| -22% | -$65.1K | ﹤0.01% | 1841 |
|
|
2013
Q2 | $216K | Buy |
+28,982
| New | +$216K | ﹤0.01% | 1943 |
|